Dev Chatterjee, Raghavendra Kamath, Sohini Das &Amp;Amp; Avishek Rakshit

Stories by Dev Chatterjee, Raghavendra Kamath, Sohini Das &Amp;Amp; Avishek Rakshit

States, Centre not on same page on digital health mission

States, Centre not on same page on digital health mission

Rediff.com   14 Oct 2021

Tamil Nadu plans parallel programme with unique user IDs

Will syringe shortage puncture India's Covid vaccine plans?

Will syringe shortage puncture India's Covid vaccine plans?

Rediff.com   14 Oct 2021

Will syringe shortage puncture India's Covid vaccine plans?

India's digital health mission likely to face privacy issues

India's digital health mission likely to face privacy issues

Rediff.com   11 Oct 2021

Lack of clarity on data-sharing persists, public health experts sceptic about the pilot that was run in six Union territories as benchmark for national roll-out

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com   30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

SBI ready to support Tata group's bid for Air India

SBI ready to support Tata group's bid for Air India

Rediff.com   28 Sep 2021

India's largest public sector bank State Bank of India (SBI) will support Tata group's bid for soon-to-be-privatised Air India by subscribing to Tata Sons debentures or funding the special purpose vehicle (SPV) set up by Tata Sons for the acquisition. Bankers said the credit rating of Tata group's holding company is "AAA" signifying high safety and a combination of Air India with its existing airline businesses would make it a formidable player - leading to a duopoly market with IndiGo. It would also open many business opportunities, including in the retail segment, an official said.

Shareholders vote down Birla nominees to board of directors

Shareholders vote down Birla nominees to board of directors

Rediff.com   25 Sep 2021

Vindhya Telelinks, Universal Cables and Birla Cable shareholders go against family's wishes.

Mystery fever in wake of falling Covid cases raises alarm

Mystery fever in wake of falling Covid cases raises alarm

Rediff.com   20 Sep 2021

The sudden spike in cases of fever in India has claimed over 100 lives in five states, including UP, MP, Bihar, Haryana, and West Bengal. In UP, Firozabad and Mathura alone have reported 72 cases.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com   17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Covid Vaccine: Syringe manufacturers are ramping up

Covid Vaccine: Syringe manufacturers are ramping up

Rediff.com   15 Sep 2021

The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Rediff.com   14 Sep 2021

Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com   14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

Real estate: Godrej, Prestige vie for Rs 10K-cr sales booking club

Real estate: Godrej, Prestige vie for Rs 10K-cr sales booking club

Rediff.com   9 Sep 2021

The real estate sector might have been caught off guard by the second wave of the Covid-19 pandemic, but large listed developers like Godrej Properties and Prestige Estates Projects soldier on undeterred. They aim to have sales bookings of Rs 10,000 crore in the next few years.

Focus on hospitals as India braces for Covid third wave

Focus on hospitals as India braces for Covid third wave

Rediff.com   1 Sep 2021

The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com   30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

Top realtors in race to enter one of world's priciest markets

Top realtors in race to enter one of world's priciest markets

Rediff.com   30 Aug 2021

Some of the country's largest listed real estate developers - DLF, Prestige Estates, and Puravankara - are foraying into the Rs 50,000-crore residential property market of Mumbai, where home prices are among the highest in the world. All of them are set to launch residential projects in the financial capital of the country, where the market is dominated by players such as Runwal, Lodha, and Oberoi Realty, among others. Leading the race is Prestige, which has lined up 6 million square feet (msf) of new launches in the city across Mulund and Byculla in the third quarter of this financial year (2021-22).

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com   25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

Why Piyush Goyal is peeved at some in India Inc

Why Piyush Goyal is peeved at some in India Inc

Rediff.com   23 Aug 2021

Union Minister of Commerce and Textiles Piyush Goyal has stirred up a hornet's nest by taking on India Inc, specifically the Tata group, which is among the companies that lobbied against the Modi government's pro-consumer draft e-commerce policies. While Goyal's comments, made at a Confederation of Indian Industry (CII) event, were streamed live on YouTube, the industry lobbying body later edited the video and subsequently withdrew the entire speech. Goyal had said the Tata group and other Indian companies often lobbied for their interest, while ignoring national interest.

How top realtors plan to transform Central Mumbai

How top realtors plan to transform Central Mumbai

Rediff.com   22 Aug 2021

One of Mumbai's biggest real estate redevelopment projects of Bombay Development Directorate's (BDD's) chawls (large buildings divided into many separate tenements, offering cheap, basic accommodation) has taken off in Central Mumbai, opening up a Rs 20,000-crore opportunity for real estate companies. It is expected to drive down real estate prices in Central Mumbai by up to 25 per cent, forecast real estate experts. Spread over 92 acres in Central Mumbai's prime localities of Worli, Lower Parel, and Dadar and consisting 195 four-storey houses, the BDD chawls were constructed in the 1920s.

D-Mart owner Radhakishan Damani enters top 100 global billionaires' club

D-Mart owner Radhakishan Damani enters top 100 global billionaires' club

Rediff.com   19 Aug 2021

Radhakishan S Damani, investor and promoter of the D-Mart supermarket chain, has broken into the elite club of the top 100 global billionaires. Damani, who grew up in a single-room apartment in Mumbai, is now ranked 98th on the Bloomberg Billionaires Index with $19.2 billion as his net worth. The index is a daily ranking of the world's richest people. The other Indians on the top 100 rich list ahead of Damani are Mukesh Ambani, Gautam Adani, Azim Premji, Shiv Nadar, and Lakshmi Mittal.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com   18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.